Not exact matches
The continuation of this line of research is opening
new avenues to identify what specific signals are
used to promote this increased neurogenic response, with views focused in targeting neurogenesis as a
therapeutic approach to promote the regeneration of lost neurons.»
These results, published in the journal Nature, could be
used to develop
new therapeutic approaches.
The Cell Surface Signalling Laboratory is interested in identifying
new therapeutic targets for both genetic and infectious diseases by
using large - scale systematic
approaches to discover receptor - ligand interactions that are essential for cellular recognition processes.
While pluripotent stem cell - based therapies are an exciting option, this
approach has several barriers to its application, although Iqbal Ahmad (University of Nebraska Medical Center, USA) has now proposed the
use of a «non ‐ cell autonomous» reprogramming strategy as a
new and improved
therapeutic approach [2].
We are now
using these technics starting from patient - derived PSC to increase our understanding and try to find
new therapeutic approaches for devastating neurodevelopmental disorders.
Dr. Lanteri is also interested in
using the OMICS
approach to identify predictive markers of disease outcome and
new therapeutic targets.
Recently a
new approach has been introduced
using therapeutic diets made from hydrolyzed proteins.
Although many of the
newer approaches are still under development and review, the
use of multimodality therapy incorporating innovative treatment modalities may offer the best
therapeutic option for dogs affected with HSA.